BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Nelson Yee, Eugene Lengerich, Kathryn Schmitz, Jennifer Maranki, Niraj Gusani, Leila Tchelebi, Heath Mackley, Karen Krok, Maria Baker, Claire Boer, Julian Yee. Frontiers in Gastrointestinal Oncology: Advances in Multi-Disciplinary Patient CareBiomedicines 2018; 6(2): 64 doi: 10.3390/biomedicines6020064
Urvi A. Shah, Amara G. Nandikolla, Lakshmi Rajdev. Immunotherapeutic Approaches to Biliary CancerCurrent Treatment Options in Oncology 2017; 18(7) doi: 10.1007/s11864-017-0486-9
Byoung Hyuck Kim, Kyubo Kim, Eui Kyu Chie, Jeanny Kwon, Jin-Young Jang, Sun Whe Kim, Do-Youn Oh, Yung-Jue Bang. Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single InstitutionCancer Research and Treatment 2017; 49(2): 473 doi: 10.4143/crt.2016.166
Amir A. Rahnemai-Azar, Allison B. Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: current management and emerging therapiesExpert Review of Gastroenterology & Hepatology 2017; 11(5): 439 doi: 10.1080/17474124.2017.1309290
Alex B. Blair, Adrian Murphy. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the futureCurrent Problems in Cancer 2018; 42(1): 49 doi: 10.1016/j.currproblcancer.2017.10.004
David Goldstein, Charlotte Lemech, Juan Valle. New molecular and immunotherapeutic approaches in biliary cancerESMO Open 2017; 2(Suppl 1): e000152 doi: 10.1136/esmoopen-2016-000152
Amit Mahipal, Anuhya Kommalapati, Sri Harsha Tella, Alexander Lim, Richard Kim. Novel targeted treatment options for advanced cholangiocarcinomaExpert Opinion on Investigational Drugs 2018; 27(9): 709 doi: 10.1080/13543784.2018.1512581
Changhoon Yoo, Do-Youn Oh, Hye Jin Choi, Masatoshi Kudo, Makoto Ueno, Shunsuke Kondo, Li-Tzong Chen, Motonobu Osada, Christoph Helwig, Isabelle Dussault, Masafumi Ikeda. Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancerJournal for ImmunoTherapy of Cancer 2020; 8(1): e000564 doi: 10.1136/jitc-2020-000564
Luxi Yin, Qi Xu, Jingjing Li, Qing Wei, Jieer Ying. The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancerMedicine 2018; 97(50): e13570 doi: 10.1097/MD.0000000000013570
Toshifumi Wakai, Masayuki Nagahashi, Yoshifumi Shimada, Pankaj Prasoon, Jun Sakata. Genetic analysis in the clinical management of biliary tract cancerAnnals of Gastroenterological Surgery 2020;  doi: 10.1002/ags3.12334
Aileen Deng, Steven Cohen. Primary and Metastatic Liver Tumors2018; : 137 doi: 10.1007/978-3-319-91977-5_11
A. M. Matilla Peña, A. Clemente Sánchez, E. Ramón Botella, D. Rincón. ColangiocarcinomaMedicine - Programa de Formación Médica Continuada Acreditado 2020; 13(12): 666 doi: 10.1016/j.med.2020.06.020
Anwaar Saeed, Robin Park, Mohammed Al-Jumayli, Raed Al-Rajabi, Weijing Sun. Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced CholangiocarcinomaClinical Colorectal Cancer 2019; 18(2): 81 doi: 10.1016/j.clcc.2019.02.005